The CA125 test measures the level of cancer antigen 125 (CA125) in the blood, which is a protein often elevated in women with ovarian cancer. While CA125 can be a useful marker for diagnosing and monitoring ovarian cancer, elevated levels can also occur in benign conditions such as endometriosis, pelvic inflammatory disease, and even during menstruation. The test is commonly used in conjunction with other diagnostic methods to assess the presence and progression of ovarian cancer, monitor treatment response, and check for recurrence after treatment. A blood sample is required for this test, and results are interpreted in the context of clinical findings and imaging studies to provide a comprehensive evaluation of a patient’s health status.
Reviews
There are no reviews yet.